Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cancer patients with COVID-19 face higher risks due to possible additional infections.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.

Older age and existing health issues increase COVID-19 death risk.

COVID-19 vaccination may cause kidney inflammation, treatable with steroids and Cellcept.

COVID-19 vaccines are generally safe for people with lupus, though some may experience mild flare symptoms.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

Five FDA-approved drugs may help block COVID-19 virus entry.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

The pandemic has pushed dermatology education and care to adopt digital solutions, which are effective and likely to continue post-pandemic.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.